GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » Accounts Receivable

Vilin Bio Med (NSE:VILINBIO) Accounts Receivable : ₹112.72 Mil (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Vilin Bio Med's accounts receivables for the quarter that ended in Sep. 2023 was ₹112.72 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Vilin Bio Med's Days Sales Outstanding for the quarter that ended in Sep. 2023 was 269.06.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Vilin Bio Med's Net-Net Working Capital per share for the quarter that ended in Sep. 2023 was ₹6.24.


Vilin Bio Med Accounts Receivable Historical Data

The historical data trend for Vilin Bio Med's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med Accounts Receivable Chart

Vilin Bio Med Annual Data
Trend Mar20 Mar21 Mar22
Accounts Receivable
72.69 76.45 77.87

Vilin Bio Med Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Sep23
Accounts Receivable 72.69 76.45 77.87 - 112.72

Vilin Bio Med Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Vilin Bio Med Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Vilin Bio Med's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=112.722/76.457*91
=269.06

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Vilin Bio Med's accounts receivable are only considered to be worth 75% of book value:

Vilin Bio Med's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(65.324+0.75 * 112.722+0.5 * 24.375-74.977
-0-0)/13.95
=6.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Vilin Bio Med Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Vilin Bio Med (NSE:VILINBIO) Business Description

Traded in Other Exchanges
N/A
Address
Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009
Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines